GE HealthCare Technologies Inc. Stock
Equities
GEHC
US36266G1076
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.39 USD | -2.24% |
|
-5.80% | +1.26% |
| 06:02pm | Rotation Tests Market Faith |  |
| 02:33pm | UBS Downgrades GE Healthcare Technologies to Sell From Neutral, Adjusts Price Target to $77 From $73 | MT |
| Capitalization | 38.86B 33.34B 31.04B 28.89B 53.91B 3,508B 58.12B 357B 140B 1,678B 146B 143B 6,149B | P/E ratio 2025 * |
18.6x | P/E ratio 2026 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise value | 43.88B 37.65B 35.06B 32.63B 60.88B 3,961B 65.63B 403B 159B 1,895B 165B 161B 6,944B | EV / Sales 2025 * |
2.14x | EV / Sales 2026 * | 1.98x |
| Free-Float |
96.76% | Yield 2025 * |
0.16% | Yield 2026 * | 0.18% |
Last Transcript: GE HealthCare Technologies Inc.
| 1 day | -2.23% | ||
| 1 week | -5.80% | ||
| Current month | +1.26% | ||
| 1 month | -1.66% | ||
| 3 months | +13.43% | ||
| 6 months | +11.64% | ||
| Current year | +1.26% |
| 1 week | 82.65 |  | 88.52 |
| 1 month | 81.74 | | 89.77 |
| Current year | 82.2 | | 89.77 |
| 1 year | 57.65 | | 94.8 |
| 3 years | 57.65 | | 94.8 |
| 5 years | 53 | | 94.8 |
| 10 years | 53 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Arduini
CEO | Chief Executive Officer | 61 | 14/12/2022 |
James Saccaro
DFI | Director of Finance/CFO | 53 | 01/06/2023 |
Taha Kass-Hout
CTO | Chief Tech/Sci/R&D Officer | - | 05/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Arduini
BRD | Director/Board Member | 61 | 14/12/2022 |
Catherine Lesjak
BRD | Director/Board Member | 67 | 14/12/2022 |
Rodney Hochman
BRD | Director/Board Member | 70 | 03/01/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.01% | 0.07% | 0 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.24% | -5.80% | -0.73% | +31.14% | 38.86B | |
| +0.14% | +2.32% | +12.53% | +5.56% | 234B | |
| -0.37% | -6.90% | -6.11% | +108.11% | 194B | |
| +0.07% | +1.11% | -0.15% | -13.57% | 168B | |
| -4.31% | -9.38% | -7.99% | +93.64% | 139B | |
| -0.33% | +0.71% | -9.05% | -6.69% | 61.18B | |
| +0.58% | -1.28% | +18.81% | +5.88% | 48.22B | |
| +0.01% | +0.06% | +2.55% | -6.15% | 41.37B | |
| -0.98% | +3.05% | +10.80% | +14.73% | 37.8B | |
| -1.77% | +1.60% | -13.53% | -38.31% | 36.03B | |
| Average | -0.94% | -0.84% | +0.71% | +19.43% | 99.8B | |
| Weighted average by Cap. | -0.83% | -1.73% | +0.96% | +33.06% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.52B 17.61B 16.4B 15.26B 28.48B 1,853B 30.7B 189B 74.17B 886B 76.97B 75.39B 3,248B | 21.41B 18.38B 17.11B 15.92B 29.71B 1,933B 32.03B 197B 77.39B 925B 80.31B 78.66B 3,389B |
| Net income | 2.11B 1.81B 1.68B 1.57B 2.92B 190B 3.15B 19.35B 7.61B 90.99B 7.9B 7.74B 333B | 2.17B 1.86B 1.73B 1.61B 3.01B 196B 3.25B 19.93B 7.84B 93.69B 8.14B 7.97B 343B |
| Net Debt | 5.03B 4.31B 4.02B 3.74B 6.97B 454B 7.52B 46.16B 18.16B 217B 18.85B 18.46B 795B | 3.62B 3.11B 2.9B 2.7B 5.03B 327B 5.42B 33.3B 13.1B 157B 13.59B 13.31B 574B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 83.10 $ | -2.58% | 853,873 |
| 14/01/26 | 85.30 $ | +0.63% | 3,776,344 |
| 13/01/26 | 84.77 $ | -2.45% | 2,709,016 |
| 12/01/26 | 86.90 $ | -0.44% | 1,966,074 |
| 09/01/26 | 87.28 $ | -1.00% | 2,991,496 |
Delayed Quote Nasdaq, January 15, 2026 at 07:32 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GEHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition